211 related articles for article (PubMed ID: 34283174)
21. Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease.
Menzel S; Thein SL
Mol Diagn Ther; 2019 Apr; 23(2):235-244. PubMed ID: 30478714
[TBL] [Abstract][Full Text] [Related]
22. Genome wide association study of fetal hemoglobin in sickle cell anemia in Tanzania.
Mtatiro SN; Singh T; Rooks H; Mgaya J; Mariki H; Soka D; Mmbando B; Msaki E; Kolder I; Thein SL; Menzel S; Cox SE; Makani J; Barrett JC
PLoS One; 2014; 9(11):e111464. PubMed ID: 25372704
[TBL] [Abstract][Full Text] [Related]
23. Genetic Modifiers of Sickle Cell Anemia Phenotype in a Cohort of Angolan Children.
Ginete C; Delgadinho M; Santos B; Miranda A; Silva C; Guerreiro P; Chimusa ER; Brito M
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674403
[TBL] [Abstract][Full Text] [Related]
24. Fetal hemoglobin in sickle cell anemia: genetic studies of the Arab-Indian haplotype.
Ngo D; Bae H; Steinberg MH; Sebastiani P; Solovieff N; Baldwin CT; Melista E; Safaya S; Farrer LA; Al-Suliman AM; Albuali WH; Al Bagshi MH; Naserullah Z; Akinsheye I; Gallagher P; Luo HY; Chui DH; Farrell JJ; Al-Ali AK; Alsultan A
Blood Cells Mol Dis; 2013 Jun; 51(1):22-6. PubMed ID: 23465615
[TBL] [Abstract][Full Text] [Related]
25. Catechol-O-methyltransferase gene (COMT) is associated with neurocognitive functioning in patients with sickle cell disease.
Heitzer AM; Rashkin SR; Trpchevska A; Longoria JN; Rampersaud E; Olufadi Y; Wang WC; Raches D; Potter B; Steinberg MH; King AA; Kang G; Takemoto CM; Hankins JS
Curr Res Transl Med; 2023 Nov; 72(2):103433. PubMed ID: 38244277
[TBL] [Abstract][Full Text] [Related]
26. The association of HBG2, BCL11A, and HMIP polymorphisms with fetal hemoglobin and clinical phenotype in Iraqi Kurds with sickle cell disease.
Al-Allawi N; Qadir SMA; Puehringer H; Chui DHK; Farrell JJ; Oberkanins C
Int J Lab Hematol; 2019 Feb; 41(1):87-93. PubMed ID: 30216683
[TBL] [Abstract][Full Text] [Related]
27. Genetic Modifiers of Sickle Cell Disease: A Genotype-Phenotype Relationship Study in a Cohort of 82 Children on Mayotte Island.
Muszlak M; Pissard S; Badens C; Chamouine A; Maillard O; Thuret I
Hemoglobin; 2015; 39(3):156-61. PubMed ID: 25806420
[TBL] [Abstract][Full Text] [Related]
28. Emerging science of hydroxyurea therapy for pediatric sickle cell disease.
Green NS; Barral S
Pediatr Res; 2014 Jan; 75(1-2):196-204. PubMed ID: 24252885
[TBL] [Abstract][Full Text] [Related]
29. SAR1a promoter polymorphisms are not associated with fetal hemoglobin in patients with sickle cell disease from Cameroon.
Pule GD; Bitoungui VJN; Chemegni BC; Kengne AP; Wonkam A
BMC Res Notes; 2017 May; 10(1):183. PubMed ID: 28499394
[TBL] [Abstract][Full Text] [Related]
30. Variation and impact of polygenic hematologic traits in monogenic sickle cell disease.
Pincez T; Lo KS; D'Orengiani APHD; Garrett ME; Brugnara C; Ashley-Koch AE; Telen MJ; Galacteros F; Joly P; Bartolucci P; Lettre G
Haematologica; 2023 Mar; 108(3):870-881. PubMed ID: 36226494
[TBL] [Abstract][Full Text] [Related]
31. rs11886868 and rs4671393 of BCL11A associated with HbF level variation and modulate clinical events among sickle cell anemia patients.
Chaouch L; Moumni I; Ouragini H; Darragi I; Kalai M; Chaouachi D; Boudrigua I; Hafsia R; Abbes S
Hematology; 2016 Aug; 21(7):425-9. PubMed ID: 27077760
[TBL] [Abstract][Full Text] [Related]
32. Genomic polymorphisms in sickle cell disease: implications for clinical diversity and treatment.
Fertrin KY; Costa FF
Expert Rev Hematol; 2010 Aug; 3(4):443-58. PubMed ID: 21083035
[TBL] [Abstract][Full Text] [Related]
33. High fetal hemoglobin level is associated with increased risk of cerebral vasculopathy in children with sickle cell disease in Mayotte.
Chamouine A; Saandi T; Muszlak M; Larmaraud J; Lambrecht L; Poisson J; Balicchi J; Pissard S; Elenga N
BMC Pediatr; 2020 Jun; 20(1):302. PubMed ID: 32563256
[TBL] [Abstract][Full Text] [Related]
34. Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation.
Galarneau G; Palmer CD; Sankaran VG; Orkin SH; Hirschhorn JN; Lettre G
Nat Genet; 2010 Dec; 42(12):1049-51. PubMed ID: 21057501
[TBL] [Abstract][Full Text] [Related]
35. Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyurea.
Green NS; Ender KL; Pashankar F; Driscoll C; Giardina PJ; Mullen CA; Clark LN; Manwani D; Crotty J; Kisselev S; Neville KA; Hoppe C; Barral S
PLoS One; 2013; 8(2):e55709. PubMed ID: 23409025
[TBL] [Abstract][Full Text] [Related]
36. The co-inheritance of alpha-thalassemia and sickle cell anemia is associated with better hematological indices and lower consultations rate in Cameroonian patients and could improve their survival.
Rumaney MB; Ngo Bitoungui VJ; Vorster AA; Ramesar R; Kengne AP; Ngogang J; Wonkam A
PLoS One; 2014; 9(6):e100516. PubMed ID: 24978191
[TBL] [Abstract][Full Text] [Related]
37. Study on the Role of Polymorphisms of the SOX-6 and MYB Genes and Fetal Hemoglobin Levels in Sicilian Patients with β-Thalassemia and Sickle Cell Disease.
Listì F; Sclafani S; Agrigento V; Barone R; Maggio A; D'Alcamo E
Hemoglobin; 2018 Mar; 42(2):103-107. PubMed ID: 30200835
[TBL] [Abstract][Full Text] [Related]
38. Genetic variants of PKLR are associated with acute pain in sickle cell disease.
Wang X; Gardner K; Tegegn MB; Dalgard CL; Alba C; Menzel S; Patel H; Pirooznia M; Fu YP; Seifuddin FT; Thein SL
Blood Adv; 2022 Jun; 6(11):3535-3540. PubMed ID: 35271708
[TBL] [Abstract][Full Text] [Related]
39. An Expert Review of Pharmacogenomics of Sickle Cell Disease Therapeutics: Not Yet Ready for Global Precision Medicine.
Mnika K; Pule GD; Dandara C; Wonkam A
OMICS; 2016 Oct; 20(10):565-574. PubMed ID: 27636225
[TBL] [Abstract][Full Text] [Related]
40. Fetal hemoglobin and alpha thalassemia modulate the phenotypic expression of HbSD-Punjab.
Patel DK; Purohit P; Dehury S; Das P; Dutta A; Meher S; Patel S; Bag S; Mashon RS; Das K
Int J Lab Hematol; 2014 Aug; 36(4):444-50. PubMed ID: 24245819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
